WCN26-6969 EVALUATING SIBEPRENLIMAB IN PATIENTS WITH IgA NEPHROPATHY: RESULTS FROM AN INTERIM ANALYSIS OF THE CHINA COHORT OF THE PHASE 3 VISIONARY TRIAL